Cilofungin
An antifungal medication
Cilofungin | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Cilofungin is an antifungal medication that was developed for the treatment of fungal infections. It belongs to the class of echinocandins, which are known for their mechanism of action that involves inhibiting the synthesis of beta-glucan, an essential component of the fungal cell wall.
Mechanism of Action[edit | edit source]
Cilofungin works by targeting the enzyme beta-(1,3)-D-glucan synthase, which is crucial for the synthesis of beta-glucan in the fungal cell wall. By inhibiting this enzyme, cilofungin disrupts the integrity of the cell wall, leading to osmotic instability and ultimately the death of the fungal cell. This mechanism is particularly effective against Candida species and some Aspergillus species.
Clinical Use[edit | edit source]
Cilofungin was primarily investigated for its use in treating systemic candidiasis and other serious fungal infections. However, its development was halted, and it was never marketed. The reasons for this include the emergence of newer echinocandins with better pharmacokinetic profiles and fewer side effects.
Pharmacokinetics[edit | edit source]
Cilofungin is administered intravenously due to its poor oral bioavailability. It is metabolized in the liver and excreted primarily through the kidneys. The pharmacokinetic properties of cilofungin, such as its half-life and distribution, were studied during its development phase.
Side Effects[edit | edit source]
The side effects of cilofungin are similar to those of other echinocandins and may include infusion-related reactions, such as fever, chills, and rash. Hepatotoxicity and nephrotoxicity were also concerns during its clinical trials.
Development and Discontinuation[edit | edit source]
Cilofungin was one of the first echinocandins to be developed, but it was eventually discontinued in favor of newer agents like caspofungin, micafungin, and anidulafungin. These newer drugs offered improved efficacy, safety, and dosing convenience.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD